Background. This study investigated biological correlates of depression in patients with idiopathic Parkinson's disease (PD). We tested the hypothesis that in patients with PD and depression, there was regional dysfunction involving brain areas previously implicated in functional imaging studies of patients with primary depression. Method. Using positron emission tomographic measurements of regional cerebral blood flow (rCBF), patterns of resting rCBF were measured in ten patiens with PD and major depression, and ten patients with PD alone. The results were compared with findings from ten patients with primary depression and ten normal controls, scanned using identical methods as part of an earlier study. Groups were matched for age, sex and symptom severity. Results. Bilateral decreases in rCBF were observed in anteromedial regions of the medial frontal cortex and the cingulate cortex (Brodmann's areas (BA) 9 and 32) in the depressed PD group, compared with those with PD alone and compared with normal controls. This regional disturbance overlapped that observed in patients with primary depression. Conclusions. The findings indicate that the medial prefrontal cortex is a common area of neural dysfunction in the manifestation of both primary depression and depression in PD.
Depression is a frequent psychiatric disturbance in the cerebral correlates of depression in two ways. patients suffering from Parkinson's disease (PD). Firstly, comparison of two patient groups who share The reported rate of depression in PD varies thesamebehaviouralcharacteristics,butwhootherconsiderably, ranging from 490 to 70Vo (Cummings, wise have different diagnoses, allows more precise 1992). More rigorous investigation suggests that interpretationofthesignificanceoffunctionaldisturbwhile depressive symptoms are common, depression ances. Secondly, if depression occurring in different meeting diagnostic criteria is less frequent (Brown diagnostic groups is associated with similar functional & MacCarthy, 1990) .
abnormalities, then this provides strong corroboration There is evidence that depression in PD has a that a particular regional deficit is indeed critical in biological basis. Firstly, depressive episodes may the manifestation of depressive states. antedatethedevelopmentof motorsymptomsof PD
In this study we wished to test two related (Fukunishi et al, l99l'1. Secondly, severity of hypotheses.Firstwehypothesisedthatintwogroups depression does not correlate with specific measures of patients with equally severe PD there will be an of motor impairment (Starkstein et al, 1990\ . In area of regional cerebral dysfunction unique to the addition, patients have remained depressed in spite of depressed group. Secondly, this regional dysfunction significant improvement in their motor functioning will involve some or all of the brain areas previously after levodopa treatment (Marsh & Markham, implicated in functional imaging studies of patients 1973). As degeneration of serotonergic and nor-with primary depression. adrenergic projections occurs alongside degeneration of dopaminergic neurons in PD, it has been suggested that depression in such patients is associated with a Method widespread monoaminergic disturbance (Fibigier, Study design 1984; Mayeux, 1990) .
Functional imaging studies of primary depression Using positron emission tomography (PET) we have demonstrated focal disturbances of frontal lobe measured resting state regional cerebral blood flow activity (Baxter et al,l989; Bench et al,1992\,leading (rCBF) in two age-and sex-matched groups of to suggestions that these regions are associated with patients with PD, one group with moderately severe the manifestation of depression. Specific regional depression (meeting DSM-III-R criteria for a major dysfunction may be related to specific clinical depressive episode; American Psychiatric Association, manifestations of depression (Bench et al, 1993 (Bench et al, ). 1987 , and the other without depression. The two Studying depression arising in different clinical groups were also matched for severity of PD (Hoehn contexts may provide additional information on & Yahr, 1967) . In order to facilitate comparison of 334 RrNG the findings in the depresed PD group with the results of an earlier study of patients with primary depression (Bench et al, 1992) , the findings of the depressed PD group were also compared directly with an age-and sex-matched group of normal controls who formed part of the comparison group in that earlier study. In addition, rCBF data from a subgroup of these patients with primary depression, age-and sex-matched to the PD groups, was compared with the results from the depressed PD group.
Subject selection
Patients with PD were recruited from two specialist movement disorder clinics where a clinical diagnosis of idiopathic Parkinson's disease had been made according to the UK Parkinson's Disease Society Brain Bank clinical diagnostic criteria. Only PD patients without dementia, and with normal cognitive function as defined by a score on the Mini-Mental State Examination (MMSE) of 27 or more (Folstein et al, 1975) , were selected. Non-depressed PD subjects selected had no history of depression.
The PET rCBF scans of normal controls and patients with primary depression that were used were not initially obtained for this study but were drawn from an earlier study of PET and depression (Bench et a|,1992) . The scans were chosen from that larger pool of subjects on the basis of being most closely matched in age to the subjects in the PD groups. None of these subjects had a history of organic brain disease or significant medical illness. Ten subjects were included in each group (see Table l ). The subjects with primary depression in Bench's study also met DSM-III-R criteria for a major depressive episode (American Psychiatric Association, 1987) .
All Parkinsonian subjects were receiving antiParkinsonian medication in routine regimens unchanged by the study. Four of the depressed PD patients were taking antidepressant medication.
The study was approved by the ethical committees of all referring hospitals and by the local committee of the Hammersmith Hospital, where the scans were performed. Permission to administer C15O2 was granted by the Administration of Radioactive Substances Advisory Committee (ARSAC). All subjects gave informed written consent.
Patient assessment
All subjects received a clinical psychiatric assessment from which the DSM-III-R diagnosis was made. Severity of mood disturbance in the PD groups and the depressed patients was also measured using the ET AL l7-item Hamilton Depression Scale (HDS: Hamilton, 1960) . Only subjects scoring 19 or more were included in the depressed group. Non-depressed PD patients were defined as those with no significant depressive symptoms elicited on clinical assessment by a neuropsychiatrist (HAR), and who scored in the non-depressed range of the HDS.
The stage of PD was described using the Hoehn & Yahr (1967) scale. The characteristics of the subjects are described in Table l. All the ratings described were obtained on the dav of the PET scan.
Scanning procedure
All subjects underwent steady-state measurement of cerebral blood flow using Cr5O, as previously described (Frackowiak et al, 1980) . Studies were performed using a PET scanner (CTI Knoxville model 931-08,/12'5. The physical performance of this scanner has been described elsewhere (Spinks el a/, 1988). Measured attenuation corrections were made with the ratio of counts in blank and transmission scans obtained using a 68Ge ring source. Emission scans were reconstructed using a Hanning filter with a cut-off frequenry of 0.5 cycles per pixel. After reconstruction and filtering, the pixel size was 2.05 mm2 and the image resolution 8.5 x 8.5 x 7.0 mm. Fifteen tomographic slices were obtained simultaneously.
All studies were performed in the supine position in a room with dimmed lights and minimal environmental noise. Subjects were asked to close their eyes during the scans. For each subject a polystyrene head mould was made which was used to ensure correct positioning in the scanner and relative head immobility . A 22 g Teflon cannula was inserted into a radial artery after Allen's test for collateral circulation and infiltration of the skin with l9o Marcain (bupivicaine). The subjects were aligned in the scanner with reference to a laser beam system so that the detectors were parallel to the orbitomeatal line. Cl5O, was administered by inhalation. For the estimation of CBF, subjects inhaled Cl5O2 (0.75 MBq/ml, flow rate 500 ml,/min) for 18 minutes. Three arterial blood samples were taken during each emission scan. These samples were centrifuged, and plasma and whole-blood activity measured in a well counter, cross-calibrated with the PET scanner. Two arterial samples were taken for estimation of haemoglobin, pCO2 and pO2. Using this information, the raw emission data were transformed into parametric images of CBF.
Data analysis
Image analysis was performed to allow within-group averaging of subject data, followed by between-group comparisons, all on a pixel-by-pixel basis. Analysis utilised SPARC workstations (Sun Microsystems Europe) using an interactive image analysis software package (aNaI-vze 3.0, Biodynamic Research Unit, Rochester, MN, USA). Functional images were checked for artefacts and corrected for yaw and roll. The 15 original planes of data (6.75 mm interplane distance) were transformed to 26 planes in standard stereotactic space (Talairach & Tournoux, 1988) . In this space each pixel represents 2x2mm, and, transaxial planes are 4 mm thick. Images were smoothed using a 1.8 cm Gaussian filter to minimise the effects of normal variations in gyral anatomy (Friston et al, l99l\ .
For each group comparison the stereotactically normalised cerebral blood flow images were adjusted for individual differences in global blood flow using an analysis ofcovariance (Friston et al,1990\ .This process generated an adjusted mean blood flow map for each of the groups, and an estimate of the error variance for rCBF at each pixel location. Differences in the adjusted group means were assessed using the / statistic, so that for each comparison an image of the pixel I values was created over all planes of the images for which there were adequate data (Friston et ol , l99l) . The / values were displayed as transverse slices and as orthogonal projections within the standard stereotactic space. The threshold for display was set to P<0.05 per plane, with a Bonferroni correction for multiple comparisons. This correction corresponded to an expected false positive rate of 1 comparison per 20 planes (Bailey et al,l99l), and it is also applied to the data in Table 3 . The maximum number of planes analysed in any of the group comparisons, representing the number of planes for which there was complete data, was 15. Figures I and 2 therefore indicate those pixels which are sufficiently different, between the two groups in each comparison, to exceed this level of significance. The locations of these pixels are displayed on orthogonal projections and cortical renderings of the brain.
Results

Clinical characteristics
Age and sex distributions were similar across all the groups Clable l). There were no significant differences between the Parkinsonian groups in MMSE or Hoehn & Yahr scores. The mean HDS score of 22 in the depressed PD group was similar to that recorded by Bench et ol (1992') in their patients with primary depression, indicating depression of moderate severity. The mean HDS item scores in each of the two depressed groups are given in Table 2 . The HDS scores were by definition significantly lower in the non-depressed PDgroup (one-wayANOVA, F: 105, P<0.000).
rCBF comparisons Depressed PD versus PD
This comparison revealed a profile of significantly decreased rCBF in the depressed PD group with respect to the non-depressed PD subjects. The changes were centred on the medial prefrontal cortex bilaterally, involving the medial frontal cortex (Brodmann's area (BA) 9) and the contiguous cingulate cortex (BA 32), extending from 28 to 32 mm above a line joining the anterior and posterior commissures (the AC-PC line). These areas are displayed in Fig. l . Given in Table 3 are the Talairach coordinates (Talairach & Tournoux, 1988) and adjusted rCBF values, as well as an associated measure of the significance of the difference (the Z score) for the pixels at which there were the most significant differences in blood flow between the two groups. The individual rCBF values at these pixels are displayed as a scatter-plot in Fig. 3 .
Depressed PD versus normal controls
Significant decreases in rCBF in the depressed PD group were observed in the medial prefrontal and anterior cingulate cortices (BA 9 and the anterior portion of BA 32 respectively). These decreases were bilateral but predominantly right-sided (Table 3 , Fig. 2, Fig. 4 ), extending from Zmm to 44mm above the AC-PC line.
PD versus normol controls
There were no significant differences between these two groups.
Depressed PD versus primary depression
No differences were observed between the two groups in BA 9 and. 32. The only significant difference between the two groups was a small area of decreased flow in the depressed PD subjects in the medial frontal cortex, BA 10, on the right side, present on only one plane at the level of the AC-PC line. 
Discussion
The principal finding of this study was of decreased rCBF in Brodmann's areas 9 and 32 in a depressed PD group compared with those with PD alone and with normal controls. There were no significant differences in BA 9 or 32 between the depressed PD group and the patients with primary depression. It may be concluded that decreased blood flow bilaterally in the medial frontal and the cingulate cortices is specifically associated with the presence of depression in association with PD. The absence of a significant difference between the non-depressed PD group and normal controls is in accordance with some (Brooks et al, 1992) but not all other PET studies. The significance of the small area of hypoperfusion in BA l0 ofthe depressed PD group is not clear. Involvement of prefrontal cortical structures in the manifestation of primary depression has been suggested by several studies. Baxter et al (1989) described decreased local cerebral metabolic rates for glucose (ICMRGD in the left anterolateral prefrontal cortex in both unipolar and bipolar depression. Bench et al (1992) examined rCBF in 33 patients with major depression and observed areas of significantly decreased blood flow in regions ofthe left dorsolateral prefrontal cortex (DLPFC) and the anterior cingulate 1. Adjusted for a global mean blood flow of 50 ml/1OO g/min. 2. A measure of the significance of the difference between the groups (the number of standard deviations from the mean t value in the (t) statistical map of the t value for the most significant pixel in the plane). P< 0. cortex, compared with nonnal controls. The DLPFC regimens of the depressed and the non-depressed and anterior cingulate regions described in that study groups with respect to dopaminergic or anticholinergic overlap with the areas of hypoperfusion in BA 9 and medication. In addition, the observation of no 32 in this study. Bench et al (1992\ also found an differences between rCBF patterns in the pure PD additional region of the left DLPFC to be hypo-group and unmedicated normal controls supports the perfused in their patients with primary depression. assertion that drug effects are unlikely to have Thisareahasbeenseentobeabnormalinpatientswith contributed to the findings of the study. chronic schizophrenia, and Liddle et al (1992) have As demonstrated in Table 2 , the greatest differences specifically associated hypoperfusion in this area to in symptoms between the two depressed groups were the syndrome of psychomotor poverty (poverty of in the pattern of sleep disturbance and in feelings speech, flatness of affect and decreased spontaneous of guilt. The results indicate that the depressed PD movement). These features are also seen in depression, group did not accumulate a greater proportion of and while they form well recognised symptoms of their HDS scores on the more somatic items than did PD, it may be that DLPFC hypoperfusion is the primary depressed group. associated with aspects of psychomotor impairment
Animal studies suggest that disturbed medial occurring within what are primarily non-motor states. prefrontal function may be implicated in the In keeping with this, Bench et al (1993) have recently aetiology of depression. In primates, lesions in reported a strong association between psychomotor the target regions of the mesocortical projections, retardation in depression and DLPFC hypoperfusion. the anterior heteromodal prefrontal cortex, lead to
To date, only one other PET study of depression a syndrome characterised by apathy and emotional in PD has been published. Mayberg et al (1990) blunting (Mesulam, 1986) . It has been demonstrated measured cerebral metabolic rates for glucose that PD patients with major depression, although (CMRGlc) in five PD patients with mild depression performing significantly worse than non-depressed (mean HDS score of 10.4), four patients with PD PD subjects in a range of cognitive tasks, are alone, and six normal controls. In a region-of-particularly impaired on frontal lobe tests (Starkstein interest analysis they found relative hypometabolism, et al, 1989) . Starkstein et al (1989) speculate that this averaged across both hemispheres, in caudate nuclei dysfunction may be secondary to pathology in the and orbital-inferior areas of the frontal lobe (BA 10, dopaminergic projections from the ventral tegmental I l, 12 and 47) in the depressed PD group. Their area (VTA) to the frontal cortex. It has been demonresults differ from those of this study, and from stratedthatdopamine-containingnerveterminalsof resting rCBF studies of primary depression (Bench VTA projections to the medial prefrontal cortex are et al, 1992). As well as studying patients with less important in the mediation of reward and reinforcesevere depression, there are several technical differ-ment processes in animals (Goeders & Smith, 1983 ; ences between the Mayberg study and the latter Fibigier, 1984) . Fibigier (1984) has pointed out that studies which may explain the discrepant findings. a reduced ability to experience pleasure or reward Mayberg et al (1990) determined cerebral activity is a cardinal feature of clinical depression. from measurement of CMRGIc using a region-ofinterest based analysis which did not include regions Conclusions in the medial prefrontal area. A reanalysis of our data using a lower threshold of significance (P< 0.01), The results of this study confirm the importance of without a correction for multiple comparisons, functional (rCBF) disturbances in the anterior medial demonstrated decreases in rCBF within the inferior-prefrontal cortex in association with states of orbital area reported by Mayberg. Thus the differ-depression in PD. Similar medial prefrontal brain ences between the two studies may reflect the fact regions have been shown to be involved in primary that the statistical parametric mapping technique, depression (Bench et al,1992) . We suggest that the using particular thresholds of significance, highlights present results, together with these previous obserareas of maximal significance in the planned com-vations, confirm the importance of the medial parison of depressed and non-depressed PD patients. prefrontal cortex in the manifestation of depression, and
In our study, four of the depressed PD patients propose that the depression of PD shares a common were receiving antidepressant medication. In a larger biological substrate with that of primary depression. PET study of primary depression, no confounding effect of medication on rCBF changes could be Acknowledgements detected (Bench et al' 1992) ' Although all the PD HARandMRTaregratefulfbrrhesupporrof theRaymondway patients were taking anti-Parkinsonian medication, rnl"-oii"i n "a. clf *as supported by a grant from the wellcome there were no systematic differences between the Trust. we thank Professor C. D. Marsden and Dr. N. Quim for
